56 related articles for article (PubMed ID: 38459885)
1. Safety of direct oral provocation test to delabel reported mild beta-lactam allergy in infants.
Cunha F; Cunha I; Gomes E
Allergol Immunopathol (Madr); 2024; 52(2):10-15. PubMed ID: 38459885
[TBL] [Abstract][Full Text] [Related]
2. Direct oral challenge for immediate and non-immediate beta-lactam allergy in children: A real-world multicenter study.
Moral L; Toral T; Muñoz C; Marco N; García-Avilés B; Murcia L; Forniés MJ; González MC; Canals F; Bragado E; Martínez Olmos J; García-Magán C; Moure González JD; Cortés N; Giménez M; Gómez C; Rodríguez AB; Moreno A; Lucas JM; Quevedo S; Blasco C; Aliaga Y
Pediatr Allergy Immunol; 2024 Mar; 35(3):e14096. PubMed ID: 38425150
[TBL] [Abstract][Full Text] [Related]
3. Is a Prolonged Drug Provocation Test Better Than a Single-Day Drug Provocation Test? A Systematic Review and Meta-Analysis.
Kulalert P; Phinyo P; Chiriac AM; Demoly P; Saokaew S; Kanchanaphoomi K; Srisuwatchari W
J Allergy Clin Immunol Pract; 2024 Feb; 12(2):431-448. PubMed ID: 38000713
[TBL] [Abstract][Full Text] [Related]
4. Challenging dogmas: Intravenous versus oral beta-lactam antibiotic provocation tests.
Molina-Molina GJ; Gómez-Duque M; Vidal Guitart X; Agustí Escasany A; Labrador-Horrillo M; Luengo O; Sala-Cunill A; Galvan-Blasco P; Guilarte M; Cardona V
World Allergy Organ J; 2024 Jun; 17(6):100914. PubMed ID: 38855082
[TBL] [Abstract][Full Text] [Related]
5. "Delabeling" by direct provocation testing in children and adolescents with a suspected history of a delayed reaction to β-lactam antibiotics: Consensus paper of Gesellschaft für pädiatrische Allergologie und Umweltmedizin (GPAU), Deutsche Gesellschaft für Allergologie und klinische Immunologie (DGAKI), and Ärzteverband deutscher Allergologen (ÄDA).
Neustädter I; Blatt S; Wurpts G; Dickel H; Walter C; Aberer W; Bode S; Buhl T; Gernert S; Harner S; Heine G; Kerzel S; Köhler M; Lange L; List J; Merk HF; Nüßlein T; Ott H; Sattler F; Schuster A; Straube H; Wedi B; Zuberbier T; Brockow K
Allergol Select; 2024; 8():206-211. PubMed ID: 38835749
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactam allergy in patients: an antibiotic stewardship challenge.
Bodega-Azuara J; Belles Medall MD; Edo-Peñarrocha J; Puplá-Bartoll A; Ferrando Piqueres R; Torres-Górriz MC; Germán-Sánchez A; Enrique E
Eur J Hosp Pharm; 2024 Jun; 31(4):307-313. PubMed ID: 36564160
[TBL] [Abstract][Full Text] [Related]
7. Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults.
Brillant-Marquis F; Proulx É; Ratnarajah K; Lavoie A; Gauthier A; Gagnon R; Boursiquot JN; Verreault N; Marois L; Bédard MA; Boivin M; Bédard PM; Ouakki M; De Serres G; Drolet JP
J Allergy Clin Immunol Pract; 2024 Feb; 12(2):451-457.e2. PubMed ID: 38572700
[TBL] [Abstract][Full Text] [Related]
8. SIAIP position paper: provocation challenge to antibiotics and non-steroidal anti-inflammatory drugs in children.
Caffarelli C; Franceschini F; Caimmi D; Mori F; Diaferio L; Di Mauro D; Mastrorilli C; Arasi S; Barni S; Bottau P; Caimmi S; Cardinale F; Comberiati P; Crisafulli G; Liotti L; Pelosi U; Saretta F; Marseglia G; Duse M; Paravati F
Ital J Pediatr; 2018 Dec; 44(1):147. PubMed ID: 30526636
[TBL] [Abstract][Full Text] [Related]
9. Are skin tests useful after benign immediate reactions to beta-lactams in children?
Mahjoub B; Marsac C; Ponvert C; Delacourt C; Faour H; Garcelon N; Lezmi G
Clin Exp Allergy; 2024 Jun; 54(6):441-443. PubMed ID: 38499330
[No Abstract] [Full Text] [Related]
10. Drug Allergy in Children: Adverse Reactions after Skin Testing.
Karavaizoglu C; Suleyman A; Yavuz Alıc R; Dolu KO; Yucel E; Demirkale ZH; Cimen SS; Ozdemir C; Tamay ZU
Int Arch Allergy Immunol; 2024; 185(1):56-62. PubMed ID: 37729879
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ ELISpot-enabled machine learning for culprit drug identification in nonimmediate drug hypersensitivity.
Chongpison Y; Sriswasdi S; Buranapraditkun S; Thantiworasit P; Rerknimitr P; Mongkolpathumrat P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C; Sukasem C; Tuchinda P; Pongcharoen P; Klaewsongkram J
J Allergy Clin Immunol; 2024 Jan; 153(1):193-202. PubMed ID: 37678574
[TBL] [Abstract][Full Text] [Related]
12. β-Lactam allergy delabeling is safe and saves costs in Primary Care.
Quiralte J; Del Robledo Ávila M; Domínguez I; Menéndez E; Cisneros JM; Guisado AB
Aten Primaria; 2024 May; 56(11):102925. PubMed ID: 38795675
[TBL] [Abstract][Full Text] [Related]
13. Knowledge gaps of drug allergy in children: a survey of primary care doctors.
Stirbiene N; Rudzeviciene O; Kapitancuke M; Nazarenkaite N; Valiulis A
Postepy Dermatol Alergol; 2021 Feb; 38(2):63-68. PubMed ID: 34408568
[TBL] [Abstract][Full Text] [Related]
14. Drug hypersensitivity reactions in Asia: regional issues and challenges.
Thong BY; Lucas M; Kang HR; Chang YS; Li PH; Tang MM; Yun J; Fok JS; Kim BK; Nagao M; Rengganis I; Tsai YG; Chung WH; Yamaguchi M; Rerkpattanapipat T; Kamchaisatian W; Leung TF; Yoon HJ; Zhang L; Latiff AHA; Fujisawa T; Thien F; Castells MC; Demoly P; Wang JY; Pawankar R
Asia Pac Allergy; 2020 Jan; 10(1):e8. PubMed ID: 32099830
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the frequency and characteristics of drug hypersensitivity reactions in hospitalized children: Real life-cohort study.
Büyük Yaytokgil Ş; Selmanoglu A; Kulhas Celik I; Şengül Emeksiz Z; Ginis T; Karaatmaca B; Toyran M; Civelek E; Dibek Misirlioğlu E
World Allergy Organ J; 2024 Apr; 17(4):100893. PubMed ID: 38601275
[TBL] [Abstract][Full Text] [Related]
16. Improving inpatient paediatric de-labelling of allergies to beta-lactams: a quality improvement study.
Wong J; Atkinson A; Timberlake K; Beck CE; Maguire B; Science M
Arch Dis Child; 2024 Apr; ():. PubMed ID: 38663978
[TBL] [Abstract][Full Text] [Related]
17. An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity.
Doña I; Caubet JC; Brockow K; Doyle M; Moreno E; Terreehorst I; Torres MJ
Clin Transl Allergy; 2018; 8():16. PubMed ID: 29760877
[TBL] [Abstract][Full Text] [Related]
18. Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis.
Pallardy M; Bechara R; Whritenour J; Mitchell-Ryan S; Herzyk D; Lebrec H; Merk H; Gourley I; Komocsar WJ; Piccotti JR; Balazs M; Sharma A; Walker DB; Weinstock D
Toxicol Sci; 2024 Jun; 200(1):11-30. PubMed ID: 38588579
[TBL] [Abstract][Full Text] [Related]
19. Integrating in vivo and ex vivo approaches for culprit drug identification in cutaneous adverse drug reactions from non-beta lactam antibiotics.
Ratanasutiranont N; Mongkolpathumrat P; Rujirawan P; Rerknimitr P; Klaewsongkram J
Exp Dermatol; 2024 Apr; 33(4):e15074. PubMed ID: 38651364
[No Abstract] [Full Text] [Related]
20. A CASE REPORT OF SUSPECTED ANGIOEDEMA IN A CHILD AFTER ADMINISTRATION OF MEBENDAZOLE, COTRIMOXAZOLE AND LEAF EXTRACTS.
Ashubu OF; Ademola AD; Asinobi AO
Ann Ib Postgrad Med; 2016 Jun; 14(1):41-43. PubMed ID: 27721685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
